Search hospitals > Ontario > LONDON
London Regional Cancer Program
Claim this profileLONDON, Ontario N6A 4L6
Global Leader in Breast Cancer
Global Leader in Prostate Cancer
Conducts research for Thyroid Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
412 reported clinical trials
22 medical researchers
Summary
London Regional Cancer Program is a medical facility located in LONDON, Ontario. This center is recognized for care of Breast Cancer, Prostate Cancer, Thyroid Cancer, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. London Regional Cancer Program is involved with conducting 412 clinical trials across 287 conditions. There are 22 research doctors associated with this hospital, such as David Palma, MD, Lucas Mendez, MD, Louise Moist, and Francisco E. Perera.Area of expertise
1Breast Cancer
Global LeaderER positive
Stage IV
HER2 negative
2Prostate Cancer
Global LeaderStage IV
Stage I
Stage II
Top PIs
David Palma, MDLondon Regional Cancer Program of the Lawson Health Research Institute6 years of reported clinical research
Studies Cancer
Studies Metastases
12 reported clinical trials
18 drugs studied
Lucas Mendez, MDLondon Regional Cancer Program2 years of reported clinical research
Studies Prostate Cancer
Studies Endometrial Cancer
7 reported clinical trials
14 drugs studied
Louise MoistLondon Health Sciences Centre1 year of reported clinical research
Studies Chronic Kidney Disease
Studies Contrast-induced Nephropathy
3 reported clinical trials
5 drugs studied
Francisco E. PereraLondon Regional Cancer Program2 years of reported clinical research
Studies Breast Cancer
Studies Vulval Intraepithelial Neoplasia
3 reported clinical trials
4 drugs studied
Clinical Trials running at London Regional Cancer Program
Breast Cancer
Bladder Cancer
Squamous Cell Carcinoma
Breast cancer
Thyroid Cancer
Brain Tumor
Prostate Cancer
Head and Neck Cancers
Skin Cancer
Melanoma
Hypofractionated Radiotherapy
for Breast Cancer
This trial compares two radiation schedules for breast cancer patients to see if a shorter, higher-dose treatment is as effective as a longer, lower-dose one.
Recruiting2 awards Phase 33 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at London Regional Cancer Program?
London Regional Cancer Program is a medical facility located in LONDON, Ontario. This center is recognized for care of Breast Cancer, Prostate Cancer, Thyroid Cancer, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. London Regional Cancer Program is involved with conducting 412 clinical trials across 287 conditions. There are 22 research doctors associated with this hospital, such as David Palma, MD, Lucas Mendez, MD, Louise Moist, and Francisco E. Perera.
Where is London Regional Cancer Program located?
The London Regional Cancer Program hospital is situated at 800 Commissioners Rd E, London, Ontario, Canada. For parking, visitors are advised to use lots P1 and P2 across from the main entrance on Level 2. Handicapped parking is available in lot P2.
Who should I call to ask about financial aid or insurance network?
For financial assistance related to cancer treatment, CancerCare's Hopeline at 800-813-4673 offers support for transportation, home care, child care, pet assistance, and wellness programs. The London Regional Cancer Program provides two patient assistance funds: the Massel-Cruickshank Breast Cancer Patient Assistance Fund and the Gene Goodreau Patient Assistance Fund, for emergency, short-term financial support. Additional resources and information can be found by contacting the London Regional Cancer Program at 519.685.8742.
What insurance does London Regional Cancer Program accept?
The London Regional Cancer Program (LRCP) at London Health Sciences Centre (LHSC) accepts insurance plans for cancer care services in Ontario, Canada, including the Ontario Health Insurance Plan (OHIP). OHIP covers most services provided by the LRCP, including radiation therapy, chemotherapy, and supportive care. For details on the acceptance of specific private insurance plans, please contact the LRCP directly.
What awards or recognition has London Regional Cancer Program received?
The London Regional Cancer Program (LRCP) at London Health Sciences Centre is renowned for its exceptional research and care, highlighted by Dr. David Palma's Canadian Cancer Society Award for Excellence. It houses the Cancer Clinical Research Unit (CCRU), facilitating and supporting clinical and translational research. Annually, the CCRU recruits 250-400 patients for 50 to 70 active trials, emphasizing its commitment to advancing cancer treatment.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.